hird Pole Therapeutics, a privately held company developing and delivering transformative life-saving cardio-pulmonary therapies, has named seasoned healthcare executive Bill Athenson as its new Chief Executive Officer, the company announced today. Click to View Article
In a matter of years, people with chronic conditions may not have to choose between pain relief and risking addiction. Click to View Article
Matt Pohlson, 41, is chief executive and co-founder of Omaze, a for-profit online fundraising company in Culver City that raffles off unique celebrity experiences and prizes to support charitable efforts and help fund nonprofits. Click to View Article
Knopp is advancing lead Kv7 platform candidate toward clinical studies in a rare pediatric epilepsy Click to View Article
Leading video platform provider sets new high-water mark for bookings, renewal, customer viewership, and company expansion. Click to View Article
This online investment- and digital-wealth-management platform was founded in 2015 by Milind Mehere, the former co-founder of online-marketing company Yodle, along with former hedge-fund managers Michael Weisz and Dennis Shields. Click to View Article
Matt Pohlson, 41, is chief executive and co-founder of Omaze, a for-profit online fundraising company in Culver City that raffles off unique celebrity experiences and prizes to support charitable efforts and help fund nonprofits. Click to View Article
Knopp Biosciences LLC today announced the start of Phase 2 dose-ranging clinical trial in moderate-to-severe eosinophilic asthma. Recruitment in the trial is underway and the first patient has been enrolled. Click to View Article
Founded in 2015, YieldStreet is a New York-based fintech startup aimed at democratising investment opportunities in non-traditional markets like real estate, marine/shipping, legal finance, commercial loans and more. Click to View Article
Orphan Drug designation allows companies a 7-year marketing exclusivity period, should the treatment be approved. Click to View Article
